Looking for the target cell of Kaposi's sarcoma-associated herpesvirus

Journal of Investigative Dermatology

Volumn 126, Issue 3, 2006, Pages 545-547

  Dupin, Nicolas ^a   Grange, Philippe A ^a  

^a Université René Descartes ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE; CANCER STAGING; CYTOPATHOLOGY; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; ENDEMIC DISEASE; ENDOTHELIUM CELL; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; KAPOSI SARCOMA; LYMPH VESSEL ENDOTHELIUM; PHENOTYPE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TARGET CELL; VIREMIA; VIRUS CARCINOGENESIS; VIRUS DETECTION;

EID: 32844461199     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700132     Document Type: Note

References (15)

1. Ambroziak JA, Blackbourn DJ, Herndier BG, Glogau RG, Gullett JH, McDonald AR et al. (1995) Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 268:582-3
2. Boshoff C, Weiss R (2002) AIDS-related malignancies. Nat Rev Cancer 22:373-82
3. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-9
4. Decker LL, Shankar P, Khan G, Freeman RB, Dezube BJ, Lieberman J et al. (1996) The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med 184:283-8
5. Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N et al. (1999) Distribution of human herpesvirus-8 infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci USA 96:4546-51
6. Grundhoff A, Ganem D (2004) Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 113:124-36
7. Hong YK, Foreman K, Shin JW, Hirakawa S, Curry CL, Sage DR et al. (2005) Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet 36:683-5
8. Jussila L, Valtola R, Partanen TA, Salven P, Heikkila P, Matikainen MT et al. (1998) Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth receptor-3. Cancer Res 58:1599-604
9. Kedes DH, Ganem D (1997) Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. J Clin Invest 99:2082-6
10. Little RF, Merced-Galindez F, Staskus K, Whitby D, Aoki Y, Humphrey R et al. (2003) A pilot study of cidofovir in patients with Kaposi sarcoma. J Infect Dis 187:149-53
11. Oksenhendler E, Carcelain G, Aoki Y, Boulanger E, Maillard A, Clauvel JP et al. (2000) High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation on multicentric Castleman disease in HIV-infected patients. Blood 96:2069-73
12. Orenstein JM, Alkan S, Blauvelt A, Jeang KT, Weinstein MD, Ganem D et al. (1997) Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy. AIDS 11:F35-45
13. Pellet C, Kerob D, Dupuy A, Carmagnat MV, Mourah S, Podgorniak MP et al. (2006) Kaposi's sarcoma-associated herpesvirus viremia is associated with the progression of classic and endemic Kaposi's sarcoma. J Invest Dermatol 126:621-7
14. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C et al. (1995) Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 346:799-802
15. Zhang X, Wang JF, Chandran B, Persaud K, Pytowski B, Fingeroth J et al. (2005) Kaposi's sarcoma-associated herpesvirus activation of vascular endothelial growth factor receptor 3 alters endothelial function and enhances infection. J Biol Chem 280:26216-24